We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Generating an in vitro gut model with physiologically relevant biophysical mucus properties
Summary
Researchers developed an in vitro gut model combining Caco-2 enterocyte-like cells and HT29-MTX goblet-like cells to generate mucus with physiologically relevant biophysical properties, characterizing the viscosity and pore size of the produced mucus to create a more complete model of the gastrointestinal epithelium for drug absorption and delivery research.
Abstract Introduction Gastrointestinal (GI) in vitro models have received lasting attention as an effective tool to model drug and nutrient absorption, study GI diseases, and design new drug delivery vehicles. A complete model of the GI epithelium should at a minimum include the two key functional components of the GI tract: mucus and the underlying epithelium. Mucus plays a key role in protecting and lubricating the GI tract, poses a barrier to orally administered therapies and pathogens, and serves as the microenvironment for the GI microbiome. These functions are reliant on the biophysical material properties of the mucus produced, including viscosity and pore size. Methods In this study, we generated in vitro models containing Caco-2 enterocyte-like cells and HT29-MTX goblet-like cells and determined the effects of coculture and mucus layer on epithelial permeability and biophysical properties of mucus using multiple particle tracking (MPT). Results We found that mucus height increased as the amount of HT29-MTX goblet-like cells increased. Additionally, we found that increasing the amount of HT29-MTX goblet-like cells within culture corresponded to an increase in mucus pore size and mucus microviscosity, measured using MPT. When compared to ex vivo mucus samples from mice and pigs, we found that a 90:10 ratio of Caco-2:HT29-MTX coculture displayed similar mucus pore size to porcine jejunum and that the mucus produced from 90:10 and 80:20 ratios of cells shared mechanical properties to porcine jejunum and ileum mucus. Conclusions GI coculture models are valuable tools in simulating the mucus barrier and can be utilized for a variety of applications including the study of GI diseases, food absorption, or therapeutic development. Biography Dr. Maisel joined the University of Maryland in January 2019 having done interdisciplinary training in nanotechnology, mucosal immunology, lymphatic immunology, and immunoengineering. She completed her PhD in Biomedical Engineering at the Johns Hopkins University in 2014 after which she was an NIH postdoctoral fellow at the University of Chicago in Molecular Engineering and Immunology. The Maisel Lab uses in vitro modeling, nanotechnology, and immunoengineering approaches to study and develop treatments for diseases at mucosal surfaces. They are interested in designing nanoparticles to take advantage of and study the interface between biological barriers, particularly the lymphatics, interstitial tissue, and mucosal surfaces, and nanoparticles. Dr. Maisel has won a number of awards, including NSF GRFP and NIH F32 fellowships as a trainee, the American Lung Association Dalsemer Award, LAM Foundation Career Development Award, an NSF CAREER Award, and an NIH NIGMS Maximizing Investigator Research Award. Her work has led to numerous high-impact publications, particularly in the field of drug delivery and mucosal immunoengineering, and several patents.
Sign in to start a discussion.
More Papers Like This
A human Caco-2-based co-culture model of the inflamed intestinal mucosa for particle toxicity studies
Researchers developed an advanced intestinal co-culture model using human Caco-2 cells to better study the toxicity of particles, including micro- and nanoplastics, on inflamed intestinal tissue. The model incorporates immune cells to simulate intestinal inflammation, providing a more physiologically relevant in vitro system for evaluating how plastic particles interact with the gut barrier under both healthy and inflamed conditions.
Development of an Inflammation-Triggered In Vitro “Leaky Gut” Model Using Caco-2/HT29-MTX-E12 Combined with Macrophage-like THP-1 Cells or Primary Human-Derived Macrophages
Researchers developed a laboratory model that mimics a damaged, leaky intestinal lining combined with immune cells to study how inflammation affects gut barrier function. The model uses human intestinal cells and immune cells to simulate the conditions seen in inflammatory bowel conditions. This type of tool is valuable for studying how microplastics might interact with and worsen gut barrier damage.
Capturing and Quantifying Particle Transcytosis with Microphysiological Intestine‐on‐Chip Models
A microphysiological intestinal model was used to quantify how nano- and microparticles cross the gut epithelium by transcytosis, providing more realistic transport data than standard Caco-2 monolayer assays. The system revealed size-dependent transport efficiency with implications for both drug delivery optimization and health risk assessment of ingested particles.
Gut-on-a-Chip Research for Drug Development: Implications of Chip Design on Preclinical Oral Bioavailability or Intestinal Disease Studies
This review examines how gut-on-a-chip laboratory devices are designed and used to study drug absorption and intestinal diseases outside the body. Researchers highlight four key design factors that influence how well these miniature gut models replicate real biological conditions. The study suggests these systems offer more realistic insights than traditional cell culture methods for understanding how drugs and food components interact with the intestinal lining.
Fate of microplastics in human digestive in vitro environment and study of the dialogue between epithelium, microbiota and mucus
Researchers used an in vitro human digestive model to track the fate of microplastics through simulated gastrointestinal conditions, investigating how MPs interact with digestive physico-chemical parameters, the epithelium, gut microbiota, and mucus layer, with particular attention to the vulnerable infant population.